Understanding how bacteria defend against viruses using CRISPR technology
Defining mechanisms of diverse CRISPR-Cas complexes
This study looks at how bacteria use a special system to remember and fight off viruses that try to infect them, which could help us develop better treatments for bacterial infections in the future.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Iowa State University NIH-funded |
| Lab location | 1 site (Ames, United States) |
| Project ID | NIH-11077338 on NIH RePORTER |
What this research studies
This research investigates the mechanisms by which bacteria use CRISPR-Cas systems to protect themselves from viral infections, specifically bacteriophages. By studying how these systems adapt and respond to infections, the research aims to uncover the molecular processes that enable bacteria to remember past infections and defend against future ones. The findings could enhance our understanding of bacterial evolution and improve the application of CRISPR technology in biomedical research and therapies. Patients may benefit indirectly through advancements in treatments for bacterial infections and related diseases.
Who could benefit from this research
Good fit: Ideal candidates for benefiting from this research include individuals with bacterial infections or those at risk of such infections.
Not a fit: Patients with viral infections that do not involve bacterial co-infections may not receive direct benefits from this research.
Why it matters
Potential benefit: If successful, this research could lead to improved therapies for bacterial infections and enhanced CRISPR technologies for medical applications.
How similar studies have performed: Other research has shown success in utilizing CRISPR technology for bacterial defense mechanisms, indicating a promising avenue for further exploration.
Where this research is happening
Ames, United States
- Iowa State University — Ames, United States (Active)
Researchers
- Principal investigator: Sashital, Dipali Gurudutt — Iowa State University
- Study coordinator: Sashital, Dipali Gurudutt
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.